The authors reply

New England Journal of Medicine

Volumn 360, Issue 21, 2009, Pages 2255-2256

  Ambati, Jayakrishna ^a   Katsanis, Nicholas ^b   Zhang, Kang ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 3;

GENETIC ASSOCIATION; GENOTYPE; INCIDENCE; LETTER; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA DEGENERATION;

EID: 66249098054     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Kleinman ME, Yamada K, Takeda A, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008;452:591-597
2. Karikó K, Bhuyan P, Capodici J, Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 2004;172:6545-6549 (Pubitemid 38669088)
3. Pirher N, Ivicak K, Pohar J, Bencina M, Jerala R. A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation. Nat Struct Mol Biol 2008;15:761-763
4. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 2002;109:1767-1779
5. Age-Related Eye Disease Study Research Group. A random ized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436 [Erratum, Arch Ophthalmol 2008;126:1251.]